This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Third Wave Technologies, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: **Vincent Tevere: Innovator in Cystic Fibrosis Detection**
Introduction
Vincent Tevere, an accomplished inventor based in Madison, Wisconsin, has made significant contributions to the field of genetic testing, particularly in the detection of cystic fibrosis. With one patent to his name, his innovative work promises advancements in how genetic mutations are identified and characterized, providing hope to many affected by this condition.
Latest Patents
Vincent's key patent, titled "CFTR allele detection assays," presents compositions and methods for detecting and characterizing mutations associated with cystic fibrosis. This invention encompasses various assays, including invasive cleavage structure assays such as the INVADER assay, designed to screen nucleic acid samples from patients for specific mutations in the CFTR gene. Notably, this patent also includes methods and kits that allow for the screening of multiple CFTR alleles within a single reaction container, showcasing the efficiency of his approach in genetic diagnostics.
Career Highlights
Vincent Tevere is affiliated with Third Wave Technologies, Inc., a company renowned for its cutting-edge developments in molecular diagnostics. His role at this innovative firm has allowed him to apply his expertise in genetics and contribute to groundbreaking research that enhances the understanding and detection of genetic disorders.
Collaborations
Throughout his career, Vincent has collaborated with talented professionals such as Molly Accola and Susan S Wigdal. These partnerships reflect a collaborative spirit conducive to innovation, combining diverse skills and knowledge to advance the field of genetic testing.
Conclusion
Vincent Tevere stands out as a pivotal figure in the innovation of cystic fibrosis detection methodologies. His singular patent exemplifies the intersection of research and practical application in genetics, indicating a bright future for advancements in patient diagnostics and treatment options. As the landscape of genetic testing continues to evolve, Vincent's contributions will undoubtedly play a role in shaping its trajectory.